| LAK T cells | Lymphokine Activated Killer T cells |
|---|---|
| RES | Reticulo-Endothelial System |
| A-LAK | adherent lymphokine-activated killer [cell] |
| LAK | lymphokine-activated killer [cells] |
| LK | left kidney; lichenoid keratosis; lymphokine |
| RES | Reserpine |
|---|---|
| RES | Reticulo Endothelial System |
| ALAK | Adherent lymphokine activated killer |
| LK | Lymphokine |
| LAK | Lymphokine (IL-2)-activated-killer |
| RES | <abbreviation> Reticuloendothelial system. (05 Mar 2000) |
|---|---|
| killer cells, lymphokine-activated | Cytolytic lymphocytes with the unique capacity of killing natural killer (nk)-resistant fresh tumour cells. They are interleukin-2-activated nk cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. Lak cells are used for adoptive immunotherapy in cancer patients. (12 Dec 1998) |
| lymphokine | <growth factor> Substance produced by a leucocyte that acts upon another cell. Examples are interleukins, interferon alpha, lymphotoxin (tumour necrosis factor alpha), granulocyte monocyte colony-stimulating factor (GM-CSF). The term is becoming less common and cytokine, a more general term, is taking over. Cytokines include lymphokines. (20 Mar 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|